Money Talks News on MSN
1 in 4 Medicare patients with dementia get risky drugs. 6 questions families should ask
The memory-care unit wants to calm Mom down with a pill. Before you say yes, there's something they may have skipped.
Dr. Siavoshi and Dr. Hitt emphasize that normal age-related forgetfulness looks different from memory changes that may be an early sign of a neurological condition. Dr. Siavoshi says that forgetting ...
AXSM's Auvelity sales surged 54.2% to $333 million in the first half of 2026. New indications could further expand its growth potential.
New research links repeated gabapentin use with increased risk, prompting cautious monitoring for gabapentin and dementia ...
ScienceAlert on MSN
This heart treatment from the 1970s could also improve memory in Alzheimer's patients
(DKart/iStockphoto/Getty Images) A little-known treatment for heart failure, developed more than half a century ago and ...
Spread the loveImagine a world where an Alzheimer’s diagnosis doesn’t automatically mean an inevitable, rapid decline.
Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimer’s revenue growth, and key risk/reward ...
What happens after you swallow a statin? Follow its journey through your body and discover the benefits and potential risks ...
Anabolic steroids are synthetic versions of male hormones. Some people who lift weights use them to build muscle faster or ...
Arrowhead Pharmaceuticals, Inc. beats on ARO-MAPT with up to 85% CSF tau cut; CNS siRNA platform gains traction. Click for ...
A new Alzheimer's disease prevention study has randomly assigned its first participant to a treatment group — a critical step known as randomization — helping researchers see if Alzheimer’s can be ...
The Food and Drug Administration (FDA) has granted Fast Track designation to AV-1959R for the prevention of Alzheimer disease in cognitively unimpaired individuals with biomarker evidence of amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results